The 22nd HMR Foundation Golf Tournament: $310,492 Raised for the Integrated Cancer Centre

Montréal, September 21, 2017 – On September 21st, some 155 golfers got together on the greens of the prestigious Club Laval-sur-le-Lac for the 22nd edition of the Hôpital Maisonneuve-Rosemont (HMR) Foundation Golf Tournament. Dedicated to the memory of Normand Beauchamp, a pioneer of Quebec’s radio scene, the fundraising event helped raise $310,492 in support of the major HMR Integrated Cancer Centre (ICC) project.

 “We wish to offer our most heartfelt thanks to the business leaders, partners and friends of the Foundation who have mobilized for this beautiful day devoted to improving the cancer patient care provided to cancer patients. We also wish to express our sincere gratitude to the Beauchamp family that has gone above and beyond for this fundraising event over the past three years,” said Lucie Drapeau, Executive Director of the HMR Foundation. “Thanks to their support, we will soon reach our $12 million objective to provide funding for the HMR Integrated Cancer Centre.”

For over 15 years, Normand Beauchamp was a close friend to the HMR and supported state-of-the-art laboratory technology. Mr. Beauchamp died of cancer in 2015. Inspired by his courage and generosity, for the past three years, his family and friends have ensured the success of the golf tournament dedicated to his memory. In three years, they have enabled us to raise an outstanding $789,673 for the future ICC.

The HMR Foundation wishes to underline the invaluable contribution of the Organizing Committee of this 22nd edition, which was co-chaired by Xavier Luydlin, Vice President, Operations and Labour Relations, Centre Bell and Mr. Marc Verreault, Vice President, Construction, Pomerleau. Finally, the Foundation wishes to thank its 2017 donor partners: Fiera Capital, Gildan, Nike, Technosport Canada and Pomerleau.

Our Cause: The Future HMR Integrated Cancer Centre

Every year, there are 100,000 oncology visits at the HMR. And this number just keeps growing. Despite its reputation for excellence and cutting-edge expertise in oncology and immunotherapy, it is currently faced with a woeful lack of space and resources. It needs a new facility that will enable it to provide even more effective care to a greater number of patients.

Estimated at over $80 million, $12 million of which will be provided by the HMR Foundation, the ICC will be appointed with ultramodern equipment and facilities dedicated to research, teaching and cancer patient care. A veritable human and medical breakthrough, it will be the only centre in Quebec to offer cutting-edge cellular therapy treatment.


Photos of the event on Facebook:

About the HMR Foundation:

As a key partner, the HMR Foundation has supported the Hôpital Maisonneuve-Rosemont (HMR) in its strategic development orientations in order to respond more effectively to patient needs since 1978. The Foundation supports projects for the ongoing improvement of patient care, to enhance teaching and to expand research thanks to financial support from individual donors, private foundations, partners and corporations. Collectively, they recognize the excellence of care provided to patients at the HMR, an outstanding hospital centre affiliated with the Université de Montréal.

Information: Josée Mercier, Communications Advisor / 514 252-3400, ext. 2858 /

These topics may be of interest to you